Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran
Tóm tắt
Từ khóa
Tài liệu tham khảo
FJ Palella Jr., 1998, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators, N Engl J Med, 338, 853, 10.1056/NEJM199803263381301
K Bakhouch, 2009, The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naive (HIV1)-infected individuals in Casablanca, Morocco, J Infect Dev Ctries, 3, 380, 10.3855/jidc.247
RM Novak, 2005, Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy, Clin Infect Dis, 40, 468, 10.1086/427212
MC Re, 2004, Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection, Int J Antimicrob Agents, 23, 164, 10.1016/j.ijantimicag.2003.06.005
MC Re, 2001, Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients, BMC Microbiol, 1, 30, 10.1186/1471-2180-1-30
PS Sullivan, 2002, Low prevalence of antiretroviral resistance among persons recently infected with human immunodeficiency virus in two US cities, Int J STD AIDS, 13, 554, 10.1258/095646202760159684
AM Wensing, 2005, Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management, J Infect Dis, 192, 958, 10.1086/432916
W Manosuthi, 2013, HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection, J Med Virol, 85, 194, 10.1002/jmv.23452
T Toni, 2007, HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Cote d'Ivoire: A 4-year survey, 2002–2006, AIDS Res Hum Retroviruses, 23, 1155, 10.1089/aid.2007.0072
DE Bennett, 2008, The World Health Organization's global strategy for prevention and assessment of HIV drug resistance, Antivir Ther, 13, 1, 10.1177/135965350801302S03
2014, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents
MA Thompson, 2012, Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel, JAMA, 308, 387, 10.1001/jama.2012.7961
AM Vandamme, 2011, European recommendations for the clinical use of HIV drug resistance testing: 2011 update, AIDS Rev, 13, 77
DE Bennett, 2008, Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment, Antivir Ther, 13, 25, 10.1177/135965350801302S04
National AIDS Committee Secretariat MoHaME. Islamic Re-public of Iran AIDS Progress Report On Monitoring of the United Nations General Assembly Special Session (UNGASS) on HIV and AIDS. March 2014. Report No.
R Khajehkazemi, 2013, HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey, Sex Transm Infect
DE Bennett, 2009, Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update, PLoS One, 4, e4724, 10.1371/journal.pone.0004724
F Jahanbakhsh, 2013, Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011, PLoS One, 8, e61864, 10.1371/journal.pone.0061864
SM Mousavi, 2010, Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study, Arch Virol, 155, 329, 10.1007/s00705-009-0583-6
SY Rhee, 2003, Human immunodeficiency virus reverse transcriptase and protease sequence database, Nucleic Acids Res, 31, 298, 10.1093/nar/gkg100
K Baesi, 2014, Antiretroviral drug resistance among antiretroviral-naive and treatment experienced patients infected with HIV in Iran, J Med Virol, 86, 1093, 10.1002/jmv.23898
W Sugiura, 1999, Prevalence of drug resistance-related mutations among HIV-1s in Japan, Jpn J Infect Dis, 52, 21, 10.7883/yoken.52.21
K Tamura, 2011, MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods, Mol Biol Evol, 28, 2731, 10.1093/molbev/msr121
AC Pineda-Pena, 2013, Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools, Infect Genet Evol, 19, 337, 10.1016/j.meegid.2013.04.032
R Hamkar, 2010, Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients, AIDS, 24, S85, 10.1097/01.aids.0000386738.32919.67
E Sanders-Buell, 2007, A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD, AIDS Res Hum Retroviruses, 23, 834, 10.1089/aid.2006.0299
G Mumtaz, 2011, HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa, Sex Transm Infect, 87, 101, 10.1136/sti.2010.043711
S Shah, 2011, Antiretroviral drug resistance mutations among treated and treatment-naive patients in Pakistan: diversity of the HIV type 1 pol gene in Pakistan, AIDS Res Hum Retroviruses, 27, 1277, 10.1089/aid.2010.0324
L Liu, 2008, Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance, AIDS, 22, 835, 10.1097/QAD.0b013e3282f5ff71
CF Perno, 2002, Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation, AIDS, 16, 619, 10.1097/00002030-200203080-00014
H Salomon, 2000, Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study, AIDS, 14, F17, 10.1097/00002030-200001280-00003